Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.

Best S, Hippe DS, Grunblatt E, Fatherree J, Chanana P, Wu F, Ivey R, Kennedy JJ, Sokolov D, Ibrahim A, Xu H, Monnat RJ Jr, Sullivan LB, Paddison P, Paulovich AG, MacPherson D

Open source

DOI
10.1038/s41467-026-75117-2
Published
2026 Jul 8
Container
Nature communications
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1038/s41467-026-75117-2,
  title = {Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.},
  author = {Best S and Hippe DS and Grunblatt E and Fatherree J and Chanana P and Wu F and Ivey R and Kennedy JJ and Sokolov D and Ibrahim A and Xu H and Monnat RJ Jr and Sullivan LB and Paddison P and Paulovich AG and MacPherson D},
  year = {2026},
  journal = {Nature communications},
  doi = {10.1038/s41467-026-75117-2},
  url = {https://doi.org/10.1038/s41467-026-75117-2}
}

RIS

TY  - JOUR
TI  - Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.
AU  - Best S
AU  - Hippe DS
AU  - Grunblatt E
AU  - Fatherree J
AU  - Chanana P
AU  - Wu F
AU  - Ivey R
AU  - Kennedy JJ
AU  - Sokolov D
AU  - Ibrahim A
AU  - Xu H
AU  - Monnat RJ Jr
AU  - Sullivan LB
AU  - Paddison P
AU  - Paulovich AG
AU  - MacPherson D
PY  - 2026
JO  - Nature communications
DO  - 10.1038/s41467-026-75117-2
UR  - https://doi.org/10.1038/s41467-026-75117-2
ER  - 

APA

S, B., DS, H., E, G., J, F., P, C., F, W., R, I., JJ, K., D, S., A, I., H, X., Jr, M. R., LB, S., P, P., AG, P., & D, M. (2026). Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.. Nature communications. https://doi.org/10.1038/s41467-026-75117-2

Source records